Psychedelic drug developers rally as Trump orders FDA to expedite reviews - Reuters
Psychedelic drug developers rally as Trump orders FDA to expedite reviews Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"the order is an 'official stamp of validation to the class,' showing that government support is real."
— Andrew Tsai , Executive
"is a substantial step towards diminishing regulatory risk for psychedelic drugs."
— Brian Abrahams , Executive
"In many cases, these experimental treatments have shown life changing potential for those suffering from severe mental illness and depression, including our cherished veterans, our veterans are having a tremendous hard time."
— Donald Trump , Politician
"I got a call from a number of people, including the great Joe Rogan, and he said, we have to do something about this."
— Donald Trump , Politician
Key People
Andrew Tsai is an analyst at Jefferies.
Brian Abrahams is an analyst at RBC.
Former president of the United States known for his aggressive economic policies.
Dr. Mehmet Oz is a television personality and former Republican candidate.
Joe Rogan is a popular podcast host known for discussing a wide range of topics, including politics.
Marty Makary is the FDA commissioner who announced Prasad's departure.
Robert F. Kennedy Jr. is an American environmental attorney and activist.
Robert F. Kennedy, Jr. is the Health and Human Services Secretary.
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPRkt5UW9leHZFZmU0NUdRWWNIR3YtM19sNlZQRXduUFFmZWs2NXVXaGdYOTVTelNWQzRkbWU0cHhPU0hFYmw3VlN4VkhnTTJYMUVtZW95U1JvNHk4dUVfWjQ1X0s4XzRwV1JMS2dGZVFFcjZTYXhaelJhZGQ3RkZOLWNqSzdKMFJHcmFSZkNjTTFaVW9hWVZJMkZGM1lUVkxXQWRSRk1DYUU3LWZCdjFtcUh0dTVMM2lYUzE2SzVaSktFaTNtWExJX2cxODc0ZUFp?oc=5" target="_blank">Psychedelic drug developers rally as Trump orders FDA to expedite reviews</a> <font color="#6f6f6f">Reuters</font>
Shares of psychedelic drug developers rose after President Trump signed an executive order directing the FDA to fast-track reviews of psychedelic drugs and boost federal research funding.
President Trump signed an executive order to speed up access to medical research and treatment based on psychedelic drugs, instructing the FDA to expedite the review of drugs like ibogaine.
Shares of psychedelic drug developers rose after President Trump signed an executive order directing the FDA to fast-track reviews of psychedelic drugs and increase federal research funding.
President Trump signed an executive order to accelerate research and approval of psychedelic-based therapies, particularly ibogaine, for conditions like PTSD, depression, and addiction.
Similar Stories
Related coverage based on topic and tags
Russian glide bomb attack on Zaporizhzhia kills at least 15 people
Children are among the victims, authorities say, and more victims could still be buried in the rubble of a large apartment block that was destroyed.
October 10, 2026 at 11:17 AMGermany sticks to Russia sanctions after Trump announcement on diesel - Reuters
Germany sticks to Russia sanctions after Trump announcement on diesel Reuters
October 10, 2026 at 10:59 AMThe midterm strategy driving Democrats deep into Trump country - Reuters
The midterm strategy driving Democrats deep into Trump country Reuters
October 10, 2026 at 10:05 AMRussian attack on Ukrainian city kills 12, a day after Trump eases diesel sanctions on Moscow - Reuters
Russian attack on Ukrainian city kills 12, a day after Trump eases diesel sanctions on Moscow Reuters
October 10, 2026 at 06:39 AM'What terminal cancer has taught me about life'
A Gloucestershire man with terminal cancer shares the life lessons he wishes he'd learned sooner.
October 10, 2026 at 06:16 AMWhat happens when you don't know your family medical history?
People who have been adopted or in care sometimes struggle to access family medical history which would be crucial to their own health.
October 10, 2026 at 05:45 AM